Analyze Global Market Access with Access & Reimbursement
Identify the major barriers and key stakeholders to drive successful market access.
- Understand how payer policies impact treatment decisions and affect market access to inform your strategic planning
- Identify opportunities for your brand to capture patient share through market access in a given country or region
- Maximize opportunities for emerging therapies by learning how predecessor brands gained favorable reimbursement – or why they stumbled
A global portfolio of brand-specific market access insights built on primary physician and payer research.
Develop strategies that help you overcome potential barriers to access and help your brands thrive, utilizing:
- Surveys from physician specialists and MCO pharmacy and medical directors
- Broad regional coverage, including disease-level analysis dedicated to the US, EU5, and select emerging markets
- Brand-specific insights on the major hurdles driving successes or stumbles for drugs on the market
- Analysis of the clinical benefits physicians and payers are looking for in emerging therapies and the kind of savings through direct and indirect costs payers are seeking